Conference Call with Alembic Pharmaceuticals Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Conference Call with CG Power and Industrial Solutions Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
We have already submitted Transcript of Analysts Institutional Investors meeting call on Financial Results for the Quarter ended March 31, 2025 on April 30, 2025 under the scrip code 144277. Now as per the discussion with officials of the Stock Exchange and as per the email received dated May 06, 2025, We are resubmitting the same disclosure under the scrip code 544277
